Lori Lieppman is a Houston, Texas based Dentist who is specialized in Dentistry. She does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Lori Lieppman is 18551 for Dentistry in Texas. Her current practice location is 8510 Almeda Genoa Rd, Houston. Patients can reach her at 832-259-0500.
Lori Lieppman is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Lori Lieppman speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Lori Lieppman
Specialization:
Dentist
Gender:
Female
Credentials:
D.D.S.
Accepts Medicare Assignment:
No
Practice Address:
8510 Almeda Genoa Rd, Houston, Texas, 77075-2243
Phone:
832-259-0500
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1447603147
NPI Enumeration Date:
18 Jul, 2016
NPI Last Update On:
14 Jun, 2019
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Lori Lieppman are as mentioned below.
License Number
Specialization
State
Status
18551
Dentistry
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 13, Bellaire, Texas
Zip:
77402-0013
Patients can reach Lori Lieppman at 8510 Almeda Genoa Rd, Houston, Texas or can call to book an appointment on 832-259-0500. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.